Foreign-Trade Zone 61-San Juan, Puerto Rico; Authorization of Production Activity, Pfizer Pharmaceuticals, LLC (Subzone 61A), (Ibuprofen Pharmaceutical Products), Guayama, Puerto Rico, 63290 [2012-25475]

Download as PDF 63290 Federal Register / Vol. 77, No. 200 / Tuesday, October 16, 2012 / Notices Dated: October 9, 2012. Elizabeth Whiteman, Acting Executive Secretary. that no further review of the activity is warranted at this time. The production activity described in the notification is authorized, subject to the FTZ Act and the Board’s regulations, including Section 400.14. [FR Doc. 2012–25286 Filed 10–15–12; 8:45 am] BILLING CODE 3510–DS–P Dated: October 11, 2012. Elizabeth Whiteman Acting Executive Secretary. DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [FR Doc. 2012–25460 Filed 10–15–12; 8:45 am] BILLING CODE P BILLING CODE P Foreign-Trade Zone 74—Baltimore, MD, Authorization of Production Activity, J.D. Neuhaus LP, (Overhead Lifting Equipment Production), Sparks, MD On June 13, 2012, the Baltimore Development Corporation, grantee of FTZ 74, submitted a notification of proposed production activity on behalf of J.D. Neuhaus LP, located in Sparks, Maryland. The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (77 FR 39209, 7/2/ 2012). The FTZ Board has determined that no further review of the activity is warranted at this time. The production activity described in the notification is authorized, subject to the FTZ Act and the Board’s regulations, including Section 400.14. Dated: October 11, 2012. Elizabeth Whiteman, Acting Executive Secretary. [FR Doc. 2012–25476 Filed 10–15–12; 8:45 am] BILLING CODE P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–44–2012] Foreign-Trade Zone 61—San Juan, Puerto Rico; Authorization of Production Activity, Pfizer Pharmaceuticals, LLC (Subzone 61A), (Ibuprofen Pharmaceutical Products), Guayama, Puerto Rico tkelley on DSK3SPTVN1PROD with NOTICES Dated: October 10, 2012. Elizabeth Whiteman, Acting Executive Secretary. [FR Doc. 2012–25475 Filed 10–15–12; 8:45 am] [B–47–2012] On June 13, 2012, the Puerto Rico Trade and Export Company, grantee of FTZ 61, submitted a notification of proposed production activity on behalf of Pfizer Pharmaceuticals, LLC (Subzone 61A) for its manufacturing facility located in Guayama, Puerto Rico. The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (77 FR 36997, 6/20/ 2012). The FTZ Board has determined VerDate Mar<15>2010 For Further Information Contact: Christopher J. Kemp at Christopher.Kemp@trade.gov or (202) 482–0862. 16:06 Oct 15, 2012 Jkt 229001 DEPARTMENT OF COMMERCE DEPARTMENT OF COMMERCE Foreign-Trade Zones Board Foreign-Trade Zones Board [B–72–2012] [B–73–2012] Foreign-Trade Zone 121—Albany, NY; Notification of Proposed Production Activity; Albany Molecular Research, Inc., Subzone 121A, (Pharmaceutical Chemicals Production), Rensselaer, NY Foreign-Trade Zone 181—Akron/ Canton, OH, Notification of Proposed Production Activity, Cimbar Performance Minerals, (Barium Sulfate Grinding), Wellsville, OH The Northeast Ohio Trade & Economic Consortium, grantee of FTZ 181, submitted a notification of proposed production activity on behalf of Cimbar Performance Minerals (Cimbar), located in Wellsville, Ohio. The notification conforming to the requirements of the regulations of the Board (15 CFR 400.22) was received on October 10, 2012. The Cimbar facility is located within Site 12 of FTZ 181. The facility is used for the grinding of raw barium sulfate into ground barium sulfate. Production under FTZ procedures could exempt Cimbar from customs duty payments on the foreign status components used in export production. On its domestic sales, Cimbar would be able to choose the duty rates during customs entry procedures that apply to ground barite (duty free) for the foreign status inputs noted below. Customs duties also could possibly be deferred or reduced on foreign status production equipment. Components and materials sourced from abroad include raw barium sulfate (duty rate of $1.25 per metric ton). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary at the address below. The closing period for their receipt is November 26, 2012. A copy of the notification will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the Board’s Web site, which is accessible via www.trade.gov/ftz. PO 00000 Frm 00003 Fmt 4703 Sfmt 4703 Albany Molecular Research, Inc. (AMRI), operator of Subzone 121A, submitted a notification of proposed production activity for its facility in Rensselaer, New York. The notification conforming to the requirements of the regulations of the Board (15 CFR 400.22) was received on September 26, 2012. Subzone 121A was originally approved by the Board in 1994 for the production of bulk pharmaceutical chemicals and intermediates under FTZ procedures at the former Sanofi Winthrop L.P. plant located at 33 Riverside Avenue in Rensselaer, New York, (Board Order 698, 7/20/1994, 59 FR 18318, 7/28/1994). AMRI is now requesting to produce an active pharmaceutical ingredient, dexpramipexole dihydrochloride monohydrate, under zone procedures at the Rensselaer facility. AMRI plans to transfer the active ingredient to another FTZ facility where it will be processed into a finished dosage pharmaceutical product (duty-free). Production under FTZ procedures could exempt AMRI from customs duty payments on the foreign status components used in export production for the additional finished product listed above. Production for the domestic market would not involve inverted tariff savings since the active ingredient is subject to the same duty rate (6.5%) as the chemical inputs. Customs duties also could possibly be deferred or reduced on foreign status production equipment. The chemicals sourced from abroad are (R)-4,5,6,7tetrahydrobenzo[d]thiazole-2,6-diamine and propyl 4-methylbenzenesulfonate. Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive E:\FR\FM\16OCN1.SGM 16OCN1

Agencies

[Federal Register Volume 77, Number 200 (Tuesday, October 16, 2012)]
[Notices]
[Page 63290]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25475]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-44-2012]


Foreign-Trade Zone 61--San Juan, Puerto Rico; Authorization of 
Production Activity, Pfizer Pharmaceuticals, LLC (Subzone 61A), 
(Ibuprofen Pharmaceutical Products), Guayama, Puerto Rico

    On June 13, 2012, the Puerto Rico Trade and Export Company, grantee 
of FTZ 61, submitted a notification of proposed production activity on 
behalf of Pfizer Pharmaceuticals, LLC (Subzone 61A) for its 
manufacturing facility located in Guayama, Puerto Rico. The 
notification was processed in accordance with the regulations of the 
FTZ Board (15 CFR part 400), including notice in the Federal Register 
inviting public comment (77 FR 36997, 6/20/2012). The FTZ Board has 
determined that no further review of the activity is warranted at this 
time. The production activity described in the notification is 
authorized, subject to the FTZ Act and the Board's regulations, 
including Section 400.14.

    Dated: October 11, 2012.
Elizabeth Whiteman
Acting Executive Secretary.
[FR Doc. 2012-25475 Filed 10-15-12; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.